du Bois A - Search Results

1

Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer.

Lück HJ, Thomssen C, du Bois A, Untch M, Lisboa B, Köhler G, Diergarten K. Lück HJ, et al. Among authors: du bois a. Semin Oncol. 1997 Oct;24(5 Suppl 17):S17-35-S17-39. Semin Oncol. 1997. PMID: 9374090 Clinical Trial.

2

Comparison of the emetogenic potential between cisplatin and carboplatin in combination with alkylating agents.

du Bois A, Vach W, Thomssen C, Karck U, Madjar H, Prömpeler H, Meerpohl HG. du Bois A, et al. Acta Oncol. 1994;33(5):531-5. doi: 10.3109/02841869409083931. Acta Oncol. 1994. PMID: 7917367 Clinical Trial.

3

Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer.

du Bois A, Meerpohl HG, Madjar H, Spinner D, Dall P, Pfisterer J, Bauknecht T. du Bois A, et al. J Cancer Res Clin Oncol. 1994;120(3):173-8. doi: 10.1007/BF01202198. J Cancer Res Clin Oncol. 1994. PMID: 8263015 Clinical Trial.

4

Paclitaxel-induced "recall" soft tissue ulcerations occurring at the site of previous subcutaneous administration of paclitaxel in low doses.

du Bois A, Kommoss FG, Pfisterer J, Lück HJ, Meerpohl HG. du Bois A, et al. Gynecol Oncol. 1996 Jan;60(1):94-6. doi: 10.1006/gyno.1996.0017. Gynecol Oncol. 1996. PMID: 8557235

5

Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.

Luck HJ, Thomssen C, duBois A, Lisboa BW, Untch M, Kuhnle H, Konecny G, Janicke F, Meerpohl HG, Lindner C, Hecker D, Diergarten K. Luck HJ, et al. Semin Oncol. 1996 Feb;23(1 Suppl 1):33-6. Semin Oncol. 1996. PMID: 8629034 Clinical Trial.

6

Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer.

Meerpohl HG, du Bois A, Kühnle H, Lück HJ, Kreienberg R, Möbus V, Bauknecht T, Köchli O, Bochtler H, Diergarten K, et al. Meerpohl HG, et al. Among authors: du bois a. Semin Oncol. 1995 Dec;22(6 Suppl 15):7-12. Semin Oncol. 1995. PMID: 8643973 Clinical Trial.

7

Pattern of carboplatin-induced emesis. The German Ondansetron Study Group.

du Bois A, Vach W, Cramer-Giraud U, Thomssen C, Glaubitz M, Fiola M. du Bois A, et al. Anticancer Drugs. 1995 Oct;6(5):645-51. doi: 10.1097/00001813-199510000-00003. Anticancer Drugs. 1995. PMID: 8845474 Clinical Trial.

8

Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer: a phase I trial.

Meerpohl HG, du Bois A, Luck HJ, Kühnle H, Möbus V, Kreienberg R, Bauknecht T, Köchli O, Bochtler H, Diergarten K. Meerpohl HG, et al. Among authors: du bois a. Semin Oncol. 1997 Feb;24(1 Suppl 2):S2-17-S2-22. Semin Oncol. 1997. PMID: 9045330 Clinical Trial.

9

Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer.

Lück HJ, Thomssen C, du Bois A, Lisboa BW, Untch M, Kühnle H, Jänicke F, Meerpohl HG, Lindner C, Konecny G, Hecker D, Diergarten K. Lück HJ, et al. Among authors: du bois a. Semin Oncol. 1997 Feb;24(1 Suppl 3):S13-6. Semin Oncol. 1997. PMID: 9071334 Clinical Trial.

10

Paclitaxel and epirubicin as first-line therapy for patients with metastatic breast cancer.

Lück HJ, Du Bois A, Thomssen C, Lisboa B, Untch M, Köhler G, Hecker D. Lück HJ, et al. Among authors: du bois a. Oncology (Williston Park). 1997 Apr;11(4 Suppl 3):34-7. Oncology (Williston Park). 1997. PMID: 9144689 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

568 results

Search Page

Filters